Skip to main content

Antibiotic Prophylaxis clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Antibiotic Prophylaxis in Patients Undergoing Elective TKA- Multi-center Trial

    Sorry, in progress, not accepting new patients

    The Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty (TKA): Multi-Center Trial is a study that will compare the effectiveness of various perioperative strategies for antibiotic delivery as prophylaxis for periprosthetic joint infections (PJI) and surgical site infection in elective primary TKA. The investigators hypothesize that a single dose of prophylactic antibiotic administered within 60 minutes before the incision is not an effective way to prevent PJI in elective primary total knee arthroplasty (TKA). The investigators also hypothesize that the prolonged delivery (24 hours) of antibiotic prophylaxis after surgery does not further reduce the incidence of PJI in elective primary TKA. Duke University is the only site recruiting both primary total knee arthroplasty and unilateral knee arthroplasty.

    San Francisco, California and other locations

Our lead scientists for Antibiotic Prophylaxis research studies include .

Last updated: